异常凝血酶原

异常凝血酶原N端F1片段及其抗血清的制备

Preparation of Abnormal Prothrombin Fl Fragment and Its Antiserum

人血浆凝血酶原和异常凝血酶原的BA-ELISA法检测

An avidin-biotin ELISA for measurement of human plasma prothrombin and abnormal prothrombin

结果表明；血浆异常凝血酶原测定具有辅助AFP诊断HCC的临床价值，对HCC与慢性肝病及良性肝占位性病变的鉴别诊断亦有帮助。

The results show that the assay for plasma abnormal prothrombin may be useful in diagnosing low AFP-producing or AFP negative HCC , and also in discriminating HCC from chronic liver diseases and benign tumors of liver .

肝癌大鼠血浆异常凝血酶原的动态变化

Dynamics of plasma abnormal prothrombin during the process of hepatocarcinogenesis in rats

肝癌大鼠异常凝血酶原的研究

Studies on Abnormal Prothrombin in Rats With Hepatocellular Carcinoma

肝癌细胞系、肝癌组织及癌旁肝硬化组织中异常凝血酶原水平的研究

Study of des - Y - carboxy prothrombin levels in hepatoma cell lines , hepatoma

同时，还研究了肝再生过程中大鼠血桨异常凝血酶原及肝内凝血酶原前体的变化。

Both the plasma abnormal prothrombin and microsomal precursors were normal during the liver regeneration in rats .

异常凝血酶原和肝细胞癌

Des-gamma-carboxy-prothrombin and Hepatocellular carcinoma

BA&ELISA检测人血浆异常凝血酶原用于原发性肝癌的诊断

Measurement of human plasma abnormal prothrombin by biotin-avidin ( ba ) ELISA in the diagnosis of hepatocellular carcinoma

结论：慢性肾功能不全的出血倾向与正常凝血酶原丢失及异常凝血酶原增加有关，后者可能由Vit.K代谢失常诱致。

Conclusion : Bleeding predisposition in patients with chronic renal insufficiency relevant to lost of normal prothrombin and increase of abnormal prothrombin , the latter may be result from vitamin k metabolic disorder .

诱癌早期的大鼠血浆即出现了高水平异常凝血酶原，它可用于肝癌的早期诊断。多瑞吉对中重度晚期肝癌疼痛早期缓解效果的研究

In contrast , there wag no abnormal prothrombin in the rat plasma during its liver regeneration . Study on early therapeutic efficacy of durogesic in moderate or severe pain of advanced liver cancer